Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.50 |
| ▸ | KDM1A | O60341 | 4/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | MPL | P40238 | 2/20 | 0.38 |
| ▸ | ACACB | O00763 | 2/20 | 0.37 |
| ▸ | RARA | P10276 | 1/20 | 0.36 |
| ▸ | RARG | P13631 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL762946 | 0.82 | ACACB (0.50) | FFAR1FFAR4ACACB | |
| SCHEMBL19845067 | 0.81 | ESR1 (0.42) | RARBFFAR1FFAR4 | |
| SCHEMBL15797758 | 0.81 | RARB (0.67) | RARBMPLRARARARGNPC1 | |
| SCHEMBL8988787 | 0.81 | RARB (0.41) | RARBKDM1AFFAR1FFAR4ACACB | |
| SCHEMBL14228880 | 0.79 | GRM5 (0.41) | RARBKDM1AFFAR1FFAR4ACACB | |
| SCHEMBL14525801 | 0.79 | RARB (0.40) | RARBKDM1AFFAR1FFAR4ACACB | |
| SCHEMBL29306100 | 0.79 | TSHR (0.46) | RARBKDM1A | |
| SCHEMBL13211613 | 0.79 | RARB (0.51) | RARBMPLACACBRARARARG | |
| SCHEMBL74657 | 0.79 | THRB (0.57) | RARBKDM1AFFAR1FFAR4ACACB | |
| SCHEMBL10923045 | 0.79 | RARB (0.56) | RARBMPLNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8139189-B2 | Liquid crystal display having particular oblique vapor deposition-alignment layer with ferroelectric liquid crystal | DAI NIPPON PRINTING CO., LTD. (JP) | 2012-03-20 | — | — | US | disclosed |
| US-8130358-B2 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8009266-B2 | Process for producing liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-7892449-B2 | Liquid crystal display and manufacturing method of same | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-02-22 | — | — | US | disclosed |
| US-7871540-B2 | Polymerizable liquid crystal composition | DIC CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-7777847-B2 | Liquid crystal display and manufacturing method of the same | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-08-17 | — | — | US | disclosed |
| US-20100060844-A1 | PROCESS FOR PRODUCING LIQUID CRYSTAL DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100053525-A1 | LIQUID CRYSTAL DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
| US-20100007832-A1 | LIQUID CRYSTAL DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
| EP-2093610-A1 | PROCESS FOR PRODUCING LIQUID CRYSTAL DISPLAY ELEMENT | Dai Nippon Printing Co., Ltd. (JP) | 2009-08-26 | — | — | EP | disclosed |
| US-7570331-B2 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-08-04 | — | — | US | disclosed |
| US-7499135-B2 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | H1-0, H1-4, H1-10 | RARB 3123/4885KDM1A 2102/4885FFAR1 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.